News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
CVS Corporation Comments on Caremark Rx Shareholder Approval of CVS/Caremark Merger
March 16, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WOONSOCKET, R.I.--(BUSINESS WIRE)--In response to the results of today’s Caremark Rx, Inc. (NYSE: CMX) shareholder vote approving the CVS/Caremark merger, CVS Corporation (NYSE: CVS) issued the following statement:
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
MORE ON THIS TOPIC
Podcast
M&A Picks Up, Walmsley Moves On, Pfizer’s MFN Deal and Hope for Huntington’s
October 1, 2025
·
2 min read
·
Heather McKenzie
Mergers & acquisitions
Genmab Buys Rising Cancer Star Merus for $8B
September 29, 2025
·
2 min read
·
Tristan Manalac
Podcast
FDA’s Autism Endeavor, Pfizer’s Obesity Comeback Bid, Psychedelics Revival, ACIP Confusion, More
September 24, 2025
·
2 min read
·
Heather McKenzie
Mergers & acquisitions
Pfizer Stages Obesity Comeback With $4.9B Metsera Acquisition
September 22, 2025
·
2 min read
·
Tristan Manalac